Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Dr. Fauci Talks COVID-19 with the ACR

Susan Bernstein  |  Issue: December 2020  |  November 10, 2020

SARS-CoV-2’s chief routes of transmission are large, respiratory droplets that fall within a few feet of being expelled by an infected person, but long-lasting aerosol droplets may cause infection, too, he said. Other bodily fluids, such as stool, blood, semen and ocular secretions, are far less important transmission sources. Fundamental prevention steps include universal mask wearing, physical distancing, avoiding indoor gatherings, conducting more activities outdoors and frequent handwashing.

“If those five public health measures were adhered to universally and consistently across the country, it is clear—from our previous experiences with other nations and even regions of our own country—it is clear that we would not be having the surging of cases that we are currently seeing,” Dr. Fauci said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Protean clinical manifestations of COVID-19 include fever, cough and fatigue, and less commonly, anorexia, shortness of breath and myalgias. Some patients report loss of smell and taste preceding the onset of respiratory symptoms, he said. According to data from 44,672 confirmed cases in China, 81% of patients had mild to moderate disease, 14% had severe illness and 5% were critical, with a fatality rate of 2.3%, although this varies. However, up to 40% of infected individuals are asymptomatic, he said.4

Multiple Risk Factors
Older adults and people of any age with certain underlying medical conditions, including cancer, chronic kidney disease, chronic obstructive pulmonary disorder (COPD), type 2 diabetes, cardiovascular disease, smoking and obesity, also are at higher risk of severe COVID-19. Dr. Fauci mentioned obesity is a paramount concern. Other possible risk factors for severe illness are use of corticosteroids or immunosuppressant medications, hypertension, pulmonary fibrosis, liver disease and being overweight, if not obese, he said. Manifestations of severe COVID-19 include hyperinflammation, neurologic disease, acute respiratory distress syndrome, cardiac dysfunction, hypercoagulability and acute kidney injury.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Another serious, rare manifestation of particular interest to rheumatologists “is a curious multi-system inflammatory syndrome first described in children, resembling Kawasaki disease, but this is also now seen in adults. There have been 800 to 1,000 cases reported globally, and 80% required ICU care, 20% required mechanical ventilation, 71% had involvement of at least four organ systems and 73% had no underlying medical conditions,” he said.6

There is a higher incidence of infections among racial and ethnic minority populations, with the highest rates in Hispanic/Latino, American Indian/Alaska Native and non-Hispanic Black communities, which may be due to higher proportions of these individuals working in jobs with high risk of exposure to SARS-CoV-2 or increased incidence of comorbidities that increase risk of severe COVID-19 disease, he said.7

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2020Anthony S. FauciCOVID-19

Related Articles

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    Space & Other Races

    October 19, 2020

    On April 5, 1950, a small group of scientists met in Silver Spring, Md., to talk about geophysics. I know this is not the most riveting way to start, but if you stick with me, I promise the story will get much more interesting. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEThis group of scientists met to discuss…

    ACR Convergence 2020

    ACR Convergence 2020: Progress Toward COVID-19 Vaccines

    November 11, 2020

    ACR CONVERGENCE 2020—A scientific session on Sunday, Nov. 8, focused on vaccine prospects in COVID-19. Dan Barouch, MD, PhD, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and the William Bosworth Castle Professor of Medicine at Harvard Medical School in Boston, shared his insights about vaccine development across…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences